$ORGS
Orgenesis Inc. Stock $orgs

$orgs Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040518 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$165.0K	$110.0K	$7.988M
YoY Change	-98.79%	-98.62%	-7.93%
Cost Of Revenue	$162.0K	$139.0K	$4.666M
YoY Change	-97.36%	-97.02%	-53.37%
Gross Profit	$3.000K	-$29.00K	$3.322M
YoY Change	-99.96%	-100.87%	-349.59%
Gross Profit Margin	1.82%	-26.36%	41.59%
Selling, General & Admin	$2.092M	$1.245M	$3.104M
YoY Change	-69.37%	-59.89%	-46.99%
% of Gross Profit	69733.33%		93.44%
Research & Development	$3.093M	$808.0K	$1.070M
YoY Change	49.85%	-24.49%	-89.31%
% of Gross Profit	103100.0%		32.21%
Depreciation & Amortization	$190.0K	$191.0K	$240.0K
YoY Change	-15.56%	-20.42%	-48.5%
% of Gross Profit	6333.33%		7.22%
Operating Expenses	$5.305M	$2.053M	$3.104M
YoY Change	-24.82%	-33.86%	-80.99%
Operating Profit	-$5.302M	-$11.75M	-$7.000K
YoY Change	-1321.66%	167800.0%	-99.91%
Interest Expense	-$761.0K	-$10.03M	-$1.375M
YoY Change	29.42%	629.45%	144.23%
% of Operating Profit
Other Income/Expense, Net	-$2.000K	-$508.0K	-$1.100M
YoY Change	-101.2%	-53.82%	-145.64%
Pretax Income	-$6.764M	-$12.26M	-$1.383M
YoY Change	514.91%	786.41%	-86.29%
Income Tax	-$141.0K	$394.0K	$25.00K
% Of Pretax Income
Net Earnings	-$6.623M	-$12.65M	-$1.356M
YoY Change	61.65%	833.11%	-86.65%
Net Earnings / Revenue	-4013.94%	-11502.73%	-16.98%
Basic Earnings Per Share		$0.43	$0.05
Diluted Earnings Per Share	-$0.22	$0.43	-$53.38K
COMMON SHARES
Basic Shares Outstanding	31.88M shares	28.47M shares	25.55M shares
Diluted Shares Outstanding		29.16M shares	25.40M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$837.0K	$100.0K	$3.015M
YoY Change	-84.24%	-96.68%	-79.79%
Cash & Equivalents	$837.0K	$55.00K	$3.015M
Short-Term Investments
Other Short-Term Assets	$2.659M	$4.700M	$2.351M
YoY Change	31.89%	99.91%	9.15%
Inventory	$34.00K	$34.00K	$95.00K
Prepaid Expenses
Receivables	$88.00K	$71.00K	$23.74M
Other Receivables	$458.0K	$3.800M	$2.651M
Total Short-Term Assets	$4.076M	$8.776M	$31.86M
YoY Change	-91.2%	-72.45%	-12.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.475M	$1.503M	$16.53M
YoY Change	-93.54%	-90.91%	142.03%
Goodwill	$1.211M	$3.703M	$7.764M
YoY Change	-85.21%	-52.31%
Intangibles	$7.375M	$7.528M	$10.72M
YoY Change	-23.92%	-29.78%
Long-Term Investments	$8.000K	$22.51M	$1.739M
YoY Change	-94.07%	1194.36%	338.04%
Other Assets	$18.00K	$716.0K	$736.0K
YoY Change	-98.24%	-2.72%	-36.55%
Total Long-Term Assets	$10.48M	$36.52M	$38.83M
YoY Change	-76.52%	-5.95%	34.55%
TOTAL ASSETS
Total Short-Term Assets	$4.076M	$8.776M	$31.86M
Total Long-Term Assets	$10.48M	$36.52M	$38.83M
Total Assets	$14.55M	$45.30M	$70.69M
YoY Change	-84.0%	-35.92%	8.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.584M	$5.000M	$4.538M
YoY Change	48.66%	10.18%	48.49%
Accrued Expenses	$2.218M	$2.015M	$5.627M
YoY Change	-13.96%	-64.19%	15.57%
Deferred Revenue	$200.0K	$120.0K	$70.00K
YoY Change	185.71%	71.43%	18.64%
Short-Term Debt	$650.0K	$430.0K	$0.00
YoY Change
Long-Term Debt Due	$2.688M	$2.600M	$22.50M
YoY Change	-41.1%	-88.45%	411.45%
Total Short-Term Liabilities	$16.41M	$14.30M	$34.17M
YoY Change	3.12%	-58.14%	151.86%
LONG-TERM LIABILITIES
Long-Term Debt	$18.97M	$18.40M	$5.186M
YoY Change	41.17%	254.8%	-29.19%
Other Long-Term Liabilities	$61.00K	$58.00K	$240.0K
YoY Change	-77.49%	-75.83%	-77.21%
Total Long-Term Liabilities	$19.13M	$18.60M	$6.272M
YoY Change	21.49%	196.56%	-25.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.41M	$14.30M	$34.17M
Total Long-Term Liabilities	$19.13M	$18.60M	$6.272M
Total Liabilities	$35.54M	$32.90M	$40.44M
YoY Change	12.26%	-18.64%	83.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$176.6M	-$142.2M	-$117.0M
YoY Change	45.97%	21.56%
Common Stock	$156.8M	$155.8M	$149.5M
YoY Change	4.31%	4.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.266M	$1.266M	$1.266M
YoY Change	0.0%	0.0%
Treasury Stock Shares			286.6K shares
Shareholders Equity	-$20.98M	$12.40M	$30.21M
YoY Change
Total Liabilities & Shareholders Equity	$14.55M	$45.30M	$70.69M
YoY Change	-84.0%	-35.92%	8.41%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$6.623M	-$12.65M	-$1.356M
YoY Change	61.65%	833.11%	-86.65%
Depreciation, Depletion And Amortization	$190.0K	$191.0K	$240.0K
YoY Change	-15.56%	-20.42%	-48.5%
Cash From Operating Activities	-$497.0K	-$1.190M	-$4.957M
YoY Change	-95.38%	-75.99%	-40.67%
INVESTING ACTIVITIES
Capital Expenditures	-$4.000K	$300.0K	-$2.619M
YoY Change	-100.07%	-111.45%	44.06%
Acquisitions
YoY Change
Other Investing Activities	-$61.00K	-$540.0K	$24.00K
YoY Change	-95.04%	-2350.0%	-100.74%
Cash From Investing Activities	-$57.00K	-$850.0K	-$2.595M
YoY Change	-99.15%	-67.24%	-48.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.228M	1.590M	9.189M
YoY Change	-93.7%	-82.7%	-229825.0%
NET CHANGE
Cash From Operating Activities	-497.0K	-1.190M	-4.957M
Cash From Investing Activities	-57.00K	-850.0K	-2.595M
Cash From Financing Activities	1.228M	1.590M	9.189M
Net Change In Cash	674.0K	-450.0K	1.637M
YoY Change	-67.07%	-127.49%	-112.18%
FREE CASH FLOW
Cash From Operating Activities	-$497.0K	-$1.190M	-$4.957M
Capital Expenditures	-$4.000K	$300.0K	-$2.619M
Free Cash Flow	-$493.0K	-$1.490M	-$2.338M
YoY Change	-96.96%	-36.27%	-64.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001460602
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		usd
CY2023Q3	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent		usd
CY2023Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount		usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2022Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q3	ORGS	Release Of Translation Adjustment Due To Deconsolidation Of Octomera ReleaseOfTranslationAdjustmentDueToDeconsolidationOfOctomera		usd
CY2022Q3	ORGS	Release Of Translation Adjustment Due To Deconsolidation Of Octomera ReleaseOfTranslationAdjustmentDueToDeconsolidationOfOctomera		usd
	ORGS	Release Of Translation Adjustment Due To Deconsolidation Of Octomera ReleaseOfTranslationAdjustmentDueToDeconsolidationOfOctomera		usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest		usd
	ORGS	Stock Issued During Period Value Issuance Of Shares Due To Exercise Of Warrants StockIssuedDuringPeriodValueIssuanceOfSharesDueToExerciseOfWarrants		usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
	ORGS	Proceeds From Repayment Of Convertible Loan To Related Party Partners ProceedsFromRepaymentOfConvertibleLoanToRelatedPartyPartners		usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	ORGS	Impact To Cash Resulting From Deconsolidation ImpactToCashResultingFromDeconsolidation		usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	ORGS	Extinguishment In Connection With Convertible Loan Restructuring ExtinguishmentInConnectionWithConvertibleLoanRestructuring		usd
	ORGS	Elimination Of Acquisition Receivables EliminationOfAcquisitionReceivables		usd
	ORGS	Accounts Receivable Deconsolidation AccountsReceivableDeconsolidation		usd
	ORGS	Contract With Customer Liability Deconsolidation ContractWithCustomerLiabilityDeconsolidation		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity File Number EntityFileNumber	001-38416
	dei	Entity Registrant Name EntityRegistrantName	ORGENESIS INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0583166
	dei	Entity Address Address Line1 EntityAddressAddressLine1	20271 Goldenrod Lane
	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876
	dei	City Area Code CityAreaCode	(480)
	dei	Local Phone Number LocalPhoneNumber	659-6404
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	ORGS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	31877063	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	55000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5311000	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	734000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1058000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	71000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36183000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4031000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	958000	usd
CY2023Q3	ORGS	Convertible Loan To Related Party ConvertibleLoanToRelatedParty	2799000	usd
CY2022Q4	ORGS	Convertible Loan To Related Party ConvertibleLoanToRelatedParty	2688000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	34000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	120000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	8776000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	46318000	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	40000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	331000	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	22509000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	39000	usd
CY2023Q3	ORGS	Loans To Associates LoansToAssociates	93000	usd
CY2022Q4	ORGS	Loans To Associates LoansToAssociates	96000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1503000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22834000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7528000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9694000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	431000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2304000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	3703000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8187000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	103000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	716000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1022000	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	36523000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	44610000	usd
CY2023Q3	us-gaap	Assets Assets	45299000	usd
CY2022Q4	us-gaap	Assets Assets	90928000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2015000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2648000	usd
CY2023Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	915000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	289000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	807000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1860000	usd
CY2023Q3	ORGS	Advance Payments On Account Of Grant AdvancePaymentsOnAccountOfGrant	1376000	usd
CY2022Q4	ORGS	Advance Payments On Account Of Grant AdvancePaymentsOnAccountOfGrant	1578000	usd
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	430000	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	60000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	220000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	542000	usd
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2540000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	4504000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14302000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15910000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	140000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1728000	usd
CY2023Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	18394000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	13343000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	163000	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	8000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	95000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	58000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	415000	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	18600000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15744000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	32902000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	31654000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	30203000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	145833334	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	145833334	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30753374	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25832322	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30466807	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25545755	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	155819000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	150355000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	71000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-270000	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	286567	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	286567	shares
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	1266000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1266000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-142230000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-121261000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	12397000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27561000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	1510000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12397000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29071000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	45299000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90928000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7841000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14129000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21117000	usd
CY2023Q3	us-gaap	Revenues Revenues	110000	usd
CY2022Q3	us-gaap	Revenues Revenues	7988000	usd
	us-gaap	Revenues Revenues	14129000	usd
	us-gaap	Revenues Revenues	22401000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	139000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	983000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6093000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2760000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-29000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	7005000	usd
	us-gaap	Gross Profit GrossProfit	8036000	usd
	us-gaap	Gross Profit GrossProfit	19641000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	808000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3683000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7616000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18172000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	153000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	225000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	568000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	686000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1245000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3104000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8621000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8758000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9518000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-274000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9517000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1189000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11753000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-281000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18286000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9164000	usd
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2000	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	4000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	6000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-283000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-508000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1100000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1807000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1702000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	411000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12259000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1383000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19961000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10860000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	394000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	614000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-12653000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-1408000	usd
	us-gaap	Profit Loss ProfitLoss	-20575000	usd
	us-gaap	Profit Loss ProfitLoss	-10897000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-52000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	394000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-105000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-12653000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1356000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-20969000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10792000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29162459	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29162459	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25403907	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25403907	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27933067	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27933067	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24944814	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24944814	shares
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-12653000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-1408000	usd
	us-gaap	Profit Loss ProfitLoss	-20575000	usd
	us-gaap	Profit Loss ProfitLoss	-10897000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-9000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	556000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	43000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	1033000	usd
	ORGS	Release Of Translation Adjustment Due To Deconsolidation Of Octomera ReleaseOfTranslationAdjustmentDueToDeconsolidationOfOctomera	-384000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	12644000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	1964000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	20234000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	11930000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	52000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	-394000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	105000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12644000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1912000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20628000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11825000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29071000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	347000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	40000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	4341000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	449000	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	287000	usd
	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	1421000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-20717000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12397000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38631000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	646000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	48000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	574000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2175000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	100000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-11930000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	30250000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23965000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	68000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-12644000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12397000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31843000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31843000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	183000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	177000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1964000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	30250000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	30250000	usd
	us-gaap	Profit Loss ProfitLoss	-20575000	usd
	us-gaap	Profit Loss ProfitLoss	-10897000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	387000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	694000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	411000	usd
	ORGS	Share In Losses Of Associated Companies Net ShareInLossesOfAssociatedCompaniesNet	-9517000	usd
	ORGS	Share In Losses Of Associated Companies Net ShareInLossesOfAssociatedCompaniesNet	-1189000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1366000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1463000	usd
	ORGS	Increase Decrease In Effect Of Exchange Differences On Intercompany Balances IncreaseDecreaseInEffectOfExchangeDifferencesOnIntercompanyBalances	129000	usd
	ORGS	Increase Decrease In Effect Of Exchange Differences On Intercompany Balances IncreaseDecreaseInEffectOfExchangeDifferencesOnIntercompanyBalances	353000	usd
	ORGS	Net Changes In Operating Leases NetChangesInOperatingLeases	82000	usd
	ORGS	Net Changes In Operating Leases NetChangesInOperatingLeases	58000	usd
	ORGS	Change In Interest Expenses Accrued On Loans And Convertible Loans ChangeInInterestExpensesAccruedOnLoansAndConvertibleLoans	-769000	usd
	ORGS	Change In Interest Expenses Accrued On Loans And Convertible Loans ChangeInInterestExpensesAccruedOnLoansAndConvertibleLoans	-764000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-283000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8076000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8838000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1598000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-308000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	389000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-10000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-17000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3925000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1574000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	266000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2379000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	135000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	32000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-9000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14335000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14163000	usd
	ORGS	Proceeds From Repayment Of Convertible Loan To Related Party Partners ProceedsFromRepaymentOfConvertibleLoanToRelatedPartyPartners	538000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	2578000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	782000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	71000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2096000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6971000	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	702000	usd
	ORGS	Impact To Cash Resulting From Deconsolidation ImpactToCashResultingFromDeconsolidation	973000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	543000	usd
	ORGS	Repayment Of Investment In Longterm Deposits RepaymentOfInvestmentInLongtermDeposits	33000	usd
	ORGS	Repayment Of Investment In Longterm Deposits RepaymentOfInvestmentInLongtermDeposits	2000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3645000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7458000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	4341000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2181000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5660000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	19150000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	5000000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3000000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2300000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	33000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	20000	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	425000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1413000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	329000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12393000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20095000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5587000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1526000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6369000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5974000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	789000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4467000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	752000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	432000	usd
	ORGS	Increase Decrease In Accounts Payable Related To Purchase Of Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToPurchaseOfPropertyPlantAndEquipment	14000	usd
	ORGS	Increase Decrease In Accounts Payable Related To Purchase Of Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToPurchaseOfPropertyPlantAndEquipment	-368000	usd
	us-gaap	Stock Issued1 StockIssued1	100000	usd
	ORGS	Extinguishment In Connection With Convertible Loan Restructuring ExtinguishmentInConnectionWithConvertibleLoanRestructuring	287000	usd
	us-gaap	Interest Paid Net InterestPaidNet	785000	usd
	us-gaap	Interest Paid Net InterestPaidNet	458000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-142230000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14335000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zUqzHecP7LA9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zYMRS9rpBZfa">Use of Estimates in the Preparation of Financial Statements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of our consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, judgments, and methodologies. We base our estimates on historical experience and on various other assumptions that we believe are reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity, the amount of revenues and expenses and the determination of the fair value of the retained interest of equity investment as of the deconsolidation. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zZSaNVJ6MZh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zH3ilKtmtpa4">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications have been made to the prior year’s financial statements to conform to the current year presentation. These reclassifications had no net effect on previously reported results of operations.</span></p>
CY2023Q3	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	31400000	usd
CY2023Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	6200000	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	25200000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P10Y
CY2023Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	973000	usd
CY2023Q3	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	47217000	usd
CY2023Q3	ORGS	Non Current Assets Fair Value Disclosure NonCurrentAssetsFairValueDisclosure	29443000	usd
CY2023Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	77633000	usd
CY2023Q3	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	6566000	usd
CY2023Q3	ORGS	Longterm Liabilities Fair Value Disclosure LongtermLiabilitiesFairValueDisclosure	2313000	usd
CY2023Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	8879000	usd
CY2023Q3	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	36203000	usd
CY2023Q3	us-gaap	Assets Net AssetsNet	32551000	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	22509000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	39000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14129000	usd
	us-gaap	Revenues Revenues	14129000	usd
	ORGS	Cost Of Revenue Excluding Depreciation And Amortization Expenses CostOfRevenueExcludingDepreciationAndAmortizationExpenses	5616000	usd
	ORGS	Gross Profit Excluding Depreciation And Amortization Expenses GrossProfitExcludingDepreciationAndAmortizationExpenses	8513000	usd
	ORGS	Research And Development Expense Excluding Depreciation And Amortization Expenses ResearchAndDevelopmentExpenseExcludingDepreciationAndAmortizationExpenses	7331000	usd
	ORGS	Operating Expenses Excluding Depreciation And Amortization Expenses OperatingExpensesExcludingDepreciationAndAmortizationExpenses	-8585000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9517000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	4000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1366000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-283000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1807000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	411000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19961000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21117000	usd
	us-gaap	Revenues Revenues	22401000	usd
	ORGS	Cost Of Revenue Excluding Depreciation And Amortization Expenses CostOfRevenueExcludingDepreciationAndAmortizationExpenses	2489000	usd
	ORGS	Gross Profit Excluding Depreciation And Amortization Expenses GrossProfitExcludingDepreciationAndAmortizationExpenses	19912000	usd
	ORGS	Research And Development Expense Excluding Depreciation And Amortization Expenses ResearchAndDevelopmentExpenseExcludingDepreciationAndAmortizationExpenses	17703000	usd
	ORGS	Operating Expenses Excluding Depreciation And Amortization Expenses OperatingExpensesExcludingDepreciationAndAmortizationExpenses	-8721000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1189000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	6000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1463000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1702000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10860000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110000	usd
CY2023Q3	us-gaap	Revenues Revenues	110000	usd
CY2023Q3	ORGS	Cost Of Revenue Excluding Depreciation And Amortization Expenses CostOfRevenueExcludingDepreciationAndAmortizationExpenses	134000	usd
CY2023Q3	ORGS	Gross Profit Excluding Depreciation And Amortization Expenses GrossProfitExcludingDepreciationAndAmortizationExpenses	-24000	usd
CY2023Q3	ORGS	Research And Development Expense Excluding Depreciation And Amortization Expenses ResearchAndDevelopmentExpenseExcludingDepreciationAndAmortizationExpenses	779000	usd
CY2023Q3	ORGS	Operating Expenses Excluding Depreciation And Amortization Expenses OperatingExpensesExcludingDepreciationAndAmortizationExpenses	-1241000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9518000	usd
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	191000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-508000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12259000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7841000	usd
CY2022Q3	us-gaap	Revenues Revenues	7988000	usd
CY2022Q3	ORGS	Cost Of Revenue Excluding Depreciation And Amortization Expenses CostOfRevenueExcludingDepreciationAndAmortizationExpenses	881000	usd
CY2022Q3	ORGS	Gross Profit Excluding Depreciation And Amortization Expenses GrossProfitExcludingDepreciationAndAmortizationExpenses	7107000	usd
CY2022Q3	ORGS	Research And Development Expense Excluding Depreciation And Amortization Expenses ResearchAndDevelopmentExpenseExcludingDepreciationAndAmortizationExpenses	3538000	usd
CY2022Q3	ORGS	Operating Expenses Excluding Depreciation And Amortization Expenses OperatingExpensesExcludingDepreciationAndAmortizationExpenses	-3088000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-274000	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	488000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1100000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1383000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-12653000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1356000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-20969000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10792000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29162459	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29162459	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25403907	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25403907	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27933067	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27933067	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24944814	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24944814	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2023Q3	us-gaap	Revenues Revenues	110000	usd
CY2022Q3	us-gaap	Revenues Revenues	7988000	usd
	us-gaap	Revenues Revenues	14129000	usd
	us-gaap	Revenues Revenues	22401000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36183000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15245000	usd
	ORGS	Elimination Of Acquisition Receivables EliminationOfAcquisitionReceivables	-1337000	usd
	ORGS	Accounts Receivable Additions AccountsReceivableAdditions	14167000	usd
	ORGS	Accounts Receivable Additions AccountsReceivableAdditions	21367000	usd
	ORGS	Accounts Receivable Collections AccountsReceivableCollections	-6090000	usd
	ORGS	Accounts Receivable Collections AccountsReceivableCollections	-11187000	usd
	ORGS	Exchange Rate Differences Of Accounts Receivable ExchangeRateDifferencesOfAccountsReceivable	-73000	usd
	ORGS	Exchange Rate Differences Of Accounts Receivable ExchangeRateDifferencesOfAccountsReceivable	-344000	usd
	ORGS	Accounts Receivable Deconsolidation AccountsReceivableDeconsolidation	44116000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	71000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23744000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	70000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	59000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	156000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	11000	usd
	ORGS	Contract With Customer Liability Deconsolidation ContractWithCustomerLiabilityDeconsolidation	106000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	120000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	70000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	120000	usd
	us-gaap	Loss Contingency Actions Taken By Plaintiff LossContingencyActionsTakenByPlaintiff	In the Complaint, the plaintiffs are seeking that the Court issue a declaratory remedy whereby the defendants are required to pay royalties to the plaintiffs at the rate of 7% of the sales and 24% of any and all revenues in consideration for sublicenses related to any product, service or process that contain know-how and technology of Sheba and any and all know-how and technology either developed or supervised by Prof. Ferber in the field of cell therapy, including in the category of the point-of-care platform and any and all services and products in relation to the defendants’ CDMO activity.
CY2022Q1	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	10000000

Files In Submission

Name	View Source	Status
orgs-20230930_lab.xml	Edgar Link	unprocessable
0001493152-23-040518-index-headers.html	Edgar Link	pending
0001493152-23-040518-index.html	Edgar Link	pending
0001493152-23-040518.txt	Edgar Link	pending
0001493152-23-040518-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgs-20230930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
orgs-20230930_cal.xml	Edgar Link	unprocessable
orgs-20230930_def.xml	Edgar Link	unprocessable
orgs-20230930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGS
Orgenesis Inc. Stock $orgs

2023 Q4 Form 10-Q Financial Statement

#000149315223040518 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGS Orgenesis Inc. Stock $orgs

2023 Q4 Form 10-Q Financial Statement

#000149315223040518 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGS
Orgenesis Inc. Stock $orgs